New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Vaccine to prevent a dangerous tropical disease receives approval

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea
Public Health & Prevention May 05,2024
Vaccine to prevent a dangerous tropical disease receives approval

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea
Public Health & Prevention May 05,2024
Clinicians, practices and patients all have a part to play in dealing with risks of remote GP consultations

Clinicians, practices and patients all have a part to play in dealing with risks of remote GP consultations

by University of OxfordCredit: Unsplash/CC0 Public DomainWhile most remote GP consultations are safe, the "Remote by Default" study finds that GP consultations conducted remotely carry
Oncology May 05,2024
Clinicians, practices and patients all have a part to play in dealing with risks of remote GP consultations

Clinicians, practices and patients all have a part to play in dealing with risks of remote GP consultations

by University of OxfordCredit: Unsplash/CC0 Public DomainWhile most remote GP consultations are safe, the "Remote by Default" study finds that GP consultations conducted remotely carry
Oncology May 05,2024
Number of cancer treatments provided decreased in first year of COVID-19

Number of cancer treatments provided decreased in first year of COVID-19

by Elana GotkineIn the first year of the pandemic, there was a significant decrease in the number of cancer treatments provided, resulting from a decrease in the number of cancer diagnoses, according
Oncology May 05,2024
Number of cancer treatments provided decreased in first year of COVID-19

Number of cancer treatments provided decreased in first year of COVID-19

by Elana GotkineIn the first year of the pandemic, there was a significant decrease in the number of cancer treatments provided, resulting from a decrease in the number of cancer diagnoses, according
Oncology May 05,2024
Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

by University of Massachusetts AmherstBacterial delivery of ovalbumin induces a specific CD8 T cell response. Credit:Frontiers in Immunology(2023). DOI: 10.3389/fimmu.2023.1228532A Un
Oncology May 05,2024
Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

by University of Massachusetts AmherstBacterial delivery of ovalbumin induces a specific CD8 T cell response. Credit:Frontiers in Immunology(2023). DOI: 10.3389/fimmu.2023.1228532A Un
Oncology May 05,2024
Herd protection against oral HPV infections seen among men

Herd protection against oral HPV infections seen among men

In unvaccinated men aged 18 to 59 years, the prevalence of vaccine-type oral human papillomavirus (HPV) decreased between 2009 to 2010 and 2015 to 2016, according to a research letter published in the
Oncology May 05,2024
Herd protection against oral HPV infections seen among men

Herd protection against oral HPV infections seen among men

In unvaccinated men aged 18 to 59 years, the prevalence of vaccine-type oral human papillomavirus (HPV) decreased between 2009 to 2010 and 2015 to 2016, according to a research letter published in the
Oncology May 05,2024
Exercise associated with benefit to patients with advanced colorectal cancer

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe
Oncology May 05,2024
Exercise associated with benefit to patients with advanced colorectal cancer

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe
Oncology May 05,2024
Telerehabilitation aids function, pain with advanced cancer

Telerehabilitation aids function, pain with advanced cancer

(HealthDay)—Collaborative telerehabilitation modestly improves function and pain while decreasing hospital length of stay and the need for postacute care in advanced cancer patients, according to a st
Oncology May 05,2024
Telerehabilitation aids function, pain with advanced cancer

Telerehabilitation aids function, pain with advanced cancer

(HealthDay)—Collaborative telerehabilitation modestly improves function and pain while decreasing hospital length of stay and the need for postacute care in advanced cancer patients, according to a st
Oncology May 05,2024
Chronic diseases monitored in primary care could lead to unnecessary testing

Chronic diseases monitored in primary care could lead to unnecessary testing

by University of BristolCredit: CC0 Public DomainGuidelines used by GPs to monitor chronic diseases are based on expert opinion rather than evidence, according to a review of the guidelines by Na
Oncology May 05,2024
Chronic diseases monitored in primary care could lead to unnecessary testing

Chronic diseases monitored in primary care could lead to unnecessary testing

by University of BristolCredit: CC0 Public DomainGuidelines used by GPs to monitor chronic diseases are based on expert opinion rather than evidence, according to a review of the guidelines by Na
Oncology May 05,2024
Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta
Oncology May 05,2024
Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta
Oncology May 05,2024
Performance on exercise test predicts risk of death from cardiovascular disease and cancer

Performance on exercise test predicts risk of death from cardiovascular disease and cancer

by European Society of CardiologyCredit: CC0 Public DomainPerformance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study present
Oncology May 05,2024
Performance on exercise test predicts risk of death from cardiovascular disease and cancer

Performance on exercise test predicts risk of death from cardiovascular disease and cancer

by European Society of CardiologyCredit: CC0 Public DomainPerformance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study present
Oncology May 05,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com